2018-05-22T12:49:53Z
2019-05-31T05:10:12Z
2018-05
2018-05-22T12:49:53Z
Following the 2013 alert by the European Medicines Agency (EMA) discouraging the use of hydroxyethyl-starch solutions (HES) in critically ill and burn patients, most specialized units treating burn victims have stopped using HES in this population. But, how well-founded was the EMA alert in this specific type of patient? ...
Article
Accepted version
English
Cremades; Medicaments; Malalts en estat crític; Burns and scalds; Drugs; Critically ill
Elsevier B.V.
Versió postprint del document publicat a: https://doi.org/10.1016/j.burns.2017.09.023
Burns, 2018, vol. 44, num. 3, p. 489-493
https://doi.org/10.1016/j.burns.2017.09.023
cc-by-nc-nd (c) Elsevier B.V., 2018
http://creativecommons.org/licenses/by-nc-nd/3.0/es